Clinical trial Recruiting at 1 site Interventional Ages 14 and up

Evaluating heart activity using advanced ECG technology

Official title: Evaluation of Electrocardiographic Measurements by High Density Electrode ECG

Run by University Hospital, Bordeaux · NCT04921501 · Data updated 2026-11-12

This study is testing a new heart monitoring technology to see if it can better detect heart problems in patients with serious arrhythmias compared to the standard method.

Quick facts

Study typeInterventional
Ages14 Years and up
SexAll
Enrollment1800 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations11 sites (Clermont-Ferrand and 10 other locations)
StatusRecruiting
StartedApril 6, 2021
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedDecember 24, 2024
Trial IDNCT04921501 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with documented severe ventricular arrhythmias or those at high risk for sudden cardiac events, such as those with low ejection fraction or a history of ventricular tachycardia.

Probably not a fit

Patients under 14 years old or those who are pregnant or nursing may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of high-density electrocardiography (HD ECG) with 128 body surface leads compared to conventional 12-lead ECG in detecting cardiac electrical activity. The aim is to improve sensitivity in measuring global or regional cardiac activity, particularly in patients with severe ventricular arrhythmias. By capturing more comprehensive data, the study seeks to provide additional clinical insights that could enhance patient management and treatment outcomes.

Why it matters

Potential benefit: If successful, this approach could lead to better detection and management of ventricular arrhythmias, potentially improving patient outcomes.

How similar studies have gone: While the use of high-density ECG is a novel approach, similar studies have shown promise in enhancing cardiac monitoring and diagnostics.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient managed at the Bordeaux University Hospital for assessment of documented severe ventricular arrhythmia (VF, sudden resuscitated death) or suspected (syncope, family history of sudden death, ECG or Holter abnormality) or impaired ventricular conduction, OR
* Patients managed for prophylactic ventricular defibrillator implantation, according to international recommendations: Heart disease with ejection fraction \< 35%, heart disease with sustained ventricular tachycardia, cardiomyopathies with high rhythmic risk,
* Women of childbearing age with effective contraception.

Exclusion Criteria:

* patients under 14 years old,
* pregnant or nursing woman.

Where it's running

  • Bordeaux University Hospital
    Pessac, France
    Recruiting
  • CHU Clermont-Ferrand
    Clermont-Ferrand, France
    Not yet recruiting
  • Hôpital Privé Jacques Cartier
    Massy, France
    Not yet recruiting
  • Hôpital Pitié-Salpêtrière
    Paris, France
    Not yet recruiting
  • Hôpital Bichat
    Paris, France
    Not yet recruiting
  • Hôpital européen Georges Pompidou
    Paris, France
    Not yet recruiting
Show 5 more locations
  • CHR Pontchaillou
    Rennes, France
    Not yet recruiting
  • CHU de Saint-Etienne
    Saint-Etienne, France
    Not yet recruiting
  • CHU de Toulouse
    Toulouse, France
    Not yet recruiting
  • CHU de Nancy
    Vandœuvre-lès-Nancy, France
    Not yet recruiting
  • Centre Hospitalier Princesse Grace
    Monaco, Monaco
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.